Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NETTERAPEUTEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   8.0% 9.9% 8.3% 8.8% 16.3% 11.3% 16.1% 15.9%   Credit score (0-100)   32 26 29 26 10 20 11 12   Credit rating   BB BB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   588 522 547 263 98.9 82.2 0.0 0.0   EBITDA   15.1 -45.4 63.4 1.8 -16.7 43.2 0.0 0.0   EBIT   15.1 -45.4 63.4 1.8 -16.7 43.2 0.0 0.0   Pre-tax profit (PTP)   14.8 -45.8 63.9 0.4 -17.8 41.6 0.0 0.0   Net earnings   14.8 -45.8 63.9 0.4 -17.8 41.6 0.0 0.0   Pre-tax profit without non-rec. items   14.8 -45.8 63.9 0.4 -17.8 41.6 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   122 76.2 140 140 123 164 -336 -336   Interest-bearing liabilities   0.0 0.0 0.0 8.1 0.3 0.3 336 336   Balance sheet total (assets)   354 298 306 255 182 190 0.0 0.0   Net Debt   -147 -141 -158 -178 -164 -162 336 336     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   588 522 547 263 98.9 82.2 0.0 0.0   Gross profit growth   11.8% -11.3% 4.8% -51.9% -62.4% -17.0% -100.0% 0.0%   Employees   1 1 1 1 2 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 100.0% -50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   354 298 306 255 182 190 0 0   Balance sheet change%   45.6% -15.7% 2.7% -16.8% -28.5% 4.3% -100.0% 0.0%   Added value   15.1 -45.4 63.4 1.8 -16.7 43.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.6% -8.7% 11.6% 0.7% -16.9% 52.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.1% -13.9% 21.4% 0.6% -7.4% 23.2% 0.0% 0.0%   ROI %   13.2% -45.8% 57.6% 1.2% -12.0% 30.1% 0.0% 0.0%   ROE %   12.9% -46.2% 59.1% 0.3% -13.6% 29.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   34.5% 25.5% 45.7% 57.6% 67.4% 86.5% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -968.8% 311.0% -250.0% -9,917.8% 979.6% -374.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 5.7% 0.3% 0.2% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 34.6% 37.4% 489.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   1.5 1.3 1.9 2.5 3.1 7.4 0.0 0.0   Current Ratio   1.5 1.3 1.9 2.2 3.1 7.4 0.0 0.0   Cash and cash equivalent   146.7 141.1 158.4 185.8 163.9 162.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   122.0 76.2 148.2 140.5 122.7 164.3 -167.9 -167.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   15 -45 63 2 -8 43 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   15 -45 63 2 -8 43 0 0   EBIT / employee   15 -45 63 2 -8 43 0 0   Net earnings / employee   15 -46 64 0 -9 42 0 0